RDGL · Vivos Inc · Financials
$0.05
+0.00 (+1.25%)
At close · Sep 17
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The independent registered public accounting firm has expressed substantial doubt about the Company's ability to continue as a going concern due to limited revenue, nominal cash, and accumulated deficits since inception. Management plans to pursue additional funding through debt and equity financing (including the pending 2026 Regulation A+ Offering), enhance operating performance via strategic focus on core products, process efficiencies, and cost structure improvements. There can be no assurance of success in raising working capital or achieving profitable operations, and the financial statements include no adjustments for outcomes of this uncertainty.”View the 10-Q filed Aug 12, 2026
Market Cap
$22.24M
Shares
494.21M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$68.38K
+1268.9%
FY2025
Net Income
-$3.07M
-5.3%
FY2025
Gross Margin
-87.39%
-27.6pp
FY2025
Operating Margin
-4628.68%
+47511.1pp
FY2025
Diluted EPS
-$0.01
0%
FY2025
Operating Cash Flow
-$2.06M
-22.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $99.1K | $68.38K | $4995 | $19.5K | $36.5K | $14.89K | $7000 | $9500 | — | $4054 | — | — | — | — | — | — | — | |
| $73.55K | $99.03K | $74.94K | $49.58K | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $124.76K | $128.13K | $30.98K | $25.54K | $28.78K | $12K | $5608 | $6028 | — | — | $0 | $474 | $1104 | $105.33K | $72.82K | $64.04K | $70.13K | |
| -$25.66K | -$59.76K | -$2984 | -$6036 | $7720 | $2887 | $1392 | $3472 | — | — | — | — | — | — | — | — | — | |
| — | -87.39% | -59.74% | -30.95% | 21.15% | 19.39% | 19.89% | 36.55% | — | — | — | — | — | — | — | — | — | |
| $212.09K | $352.23K | $324.63K | $732.7K | $343.8K | $286.85K | $84.67K | $67.58K | $104.21K | $203.04K | $328.03K | $149.65K | $44.27K | — | — | — | — | |
| — | — | — | — | — | — | — | — | $11.5K | $111.66K | $284.14K | $0 | $1300 | $9912 | $18.31K | $58.88K | $29.07K | |
| $304.4K | $296.56K | $241.82K | $165.77K | $151.11K | $112.04K | $109.03K | $74.33K | $98.64K | $109.46K | $432.47K | $408.31K | $401.3K | $1.22M | $1.12M | $564.66K | $544.5K | |
| — | — | — | — | — | — | — | — | — | $0 | $0 | $1339 | $5832 | $8889 | $11.16K | $6668 | $5693 | |
| $733 | — | — | — | — | — | — | — | — | $1473 | $2947 | $5672 | $11.99K | $208.63K | $483.2K | $546.39K | $545.19K | |
| $2.8M | $3.11M | $2.6M | $2.79M | $2.53M | $2.5M | $673.91K | $1.33M | $2.49M | $2.62M | $4.44M | $2.07M | $1.98M | $3.72M | $6.12M | $2.96M | $4.09M | |
| -$2.83M | -$3.17M | -$2.6M | -$2.79M | -$2.52M | -$2.5M | -$672.52K | -$1.33M | -$2.49M | -$2.62M | -$4.44M | -$2.04M | -$1.96M | -$3.58M | -$5.87M | -$2.56M | -$3.73M | |
| — | -4628.68% | -52139.82% | -14323.83% | -6898.13% | -16805.25% | -9607.44% | -13999.78% | — | -64551.41% | — | — | — | — | — | — | — | |
| -$2.54M | — | — | — | — | — | — | — | — | -$2.62M | -$4.43M | -$2.04M | -$1.94M | -$3.37M | -$5.39M | -$2.02M | -$3.18M | |
| — | — | — | — | — | $25.38K | $287.47K | $261.37K | $5.65M | $3.9M | $6.26M | $3.2M | $2.46M | $1.6M | $1.1M | $408.47K | $860.25K | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | $0 | $599 | |
| -$774.08K | $99.03K | -$306.06K | -$101.61K | $47.59K | -$25.97K | -$284.47K | -$280.12K | -$5.21M | -$3.8M | -$5.42M | $8.27M | -$16.15M | $108.81K | -$2.72M | -$187.75K | -$329.69K | |
| -$3.6M | -$3.07M | -$2.91M | -$2.89M | -$2.47M | -$2.53M | -$956.99K | -$1.61M | -$7.7M | -$6.42M | -$9.85M | $6.23M | -$18.11M | -$3.47M | -$8.59M | -$2.75M | -$4.06M | |
| — | — | — | — | — | $0 | $0 | — | — | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| -$3.6M | -$3.07M | -$2.91M | -$2.89M | -$2.47M | -$2.53M | -$956.99K | -$1.61M | -$7.7M | -$6.42M | -$9.85M | $6.23M | -$18.11M | -$3.47M | -$8.59M | -$2.75M | -$4.06M | |
| — | -4483.86% | -58267.23% | -14844.89% | -6767.75% | -16979.69% | -13671.31% | -16948.39% | — | -158330.71% | — | — | — | — | — | — | — | |
| USD/shares | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | — | — | — | — | — | -$0.06 | -$0.03 | -$0.11 | -$0.04 | -$0.07 |
| USD/shares | -$0.01 | -$0.01 | -$0.01 | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — | — | — | — | — |
| shares | — | 452.72M | 409.67M | 368.81M | 351.43M | 325.85M | 222.8M | 175.2M | 55.5M | 48.39M | 21.5M | 18.51M | 319.27M | 100.69M | 75.67M | 69.35M | 56.17M |
| shares | — | 452.72M | 409.67M | 368.81M | 351.43M | — | — | — | 444.01M | 48.39M | 21.5M | 18.51M | 13.87B | 106.74M | 62.05M | 17.13M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.08×
EV/EBIT
—
P/E (TTM)
—
Peer median 20.19×
Peer medians compare against the 71 similar-size Medical Devices companies (of 150 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 |
|---|---|---|
| IsoPet | $143,025 | — |
| Services Treatments | $88,875 | $29,995 |
| Certification | $37,483 | — |
| Polymer | $1,056 | — |
| Freight | $1,050 | — |
| Discount Certifications | -$9,995 | — |
| Discount Services | -$71,815 | -$2,000 |
| Discount IsoPet | -$121,300 | — |